Robert E. Kiss
Directeur/Membre du Conseil chez Biotechnology Innovation Organization
Profil
Mr. Robert E.
Kiss, CFA, is a Managing Director & Portfolio Manager at J.P.
Morgan Investment Management Ltd.
He is on the Board of Directors at Biotechnology Industry Organization.
Mr. Kiss also served on the board at CancerVax Corp.
and Micromet, Inc.
He received his undergraduate degree from Lehigh University.
Postes actifs de Robert E. Kiss
| Sociétés | Poste | Début |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Directeur/Membre du Conseil | - |
Anciens postes connus de Robert E. Kiss
| Sociétés | Poste | Fin |
|---|---|---|
| CancerVax Corp. | Directeur/Membre du Conseil | 09/05/2006 |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Directeur/Membre du Conseil | 05/05/2006 |
J.P. Morgan Investment Management Ltd.
 J.P. Morgan Investment Management Ltd. Investment ManagersFinance J.P. Morgan Investment Management Ltd. provides investment banking and financial services It also offers commercial banking, financial transaction processing, asset management, and private equity services. The company was founded on April 28, 2000 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Formation de Robert E. Kiss
| Lehigh University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
| CancerVax Corp. | Commercial Services |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Health Technology |
J.P. Morgan Investment Management Ltd.
J.P. Morgan Investment Management Ltd. Investment ManagersFinance J.P. Morgan Investment Management Ltd. provides investment banking and financial services It also offers commercial banking, financial transaction processing, asset management, and private equity services. The company was founded on April 28, 2000 and is headquartered in London, the United Kingdom. | Finance |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
